MedTrace Logo

Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

NCT00962624 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2018-09-19

No results posted yet for this study

Summary

The study involves the measurement of immune response to vaccination with three doses of a meningococcal B vaccine and a single dose of a meningococcal ACYW conjugate vaccine in healthy adults (Laboratory workers). The study will be completed at the Manchester Medical Microbiology Partnership in the UK and will enrol staff who may be at potential occupational exposure to meningococci. Blood samples will be taken before and after each vaccination and used to determine if the vaccines induce protective responses.

Conditions

  • Meningococcal Meningitis, Serogroup A
  • Meningococcal Meningitis, Serogroup B
  • Meningococcal Meningitis, Serogroup C
  • Meningococcal Meningitis, Serogroup Y
  • Meningococcal Meningitis, Serogroup W

Interventions

DRUG

meningococcal B vaccine & meningococcal ACYW conjugate vaccine

Meningococcal B vaccine will be administered at 0, 2 and 6 months and a single dose of meningococcal ACYW vaccine will be administered at 0 months, concomitantly with the first dose of the meningococcal B vaccine.

Sponsors & Collaborators

  • Novartis Vaccines

    collaborator INDUSTRY

  • Prof. Elizabeth Miller

    lead OTHER_GOV

Principal Investigators

  • Ray Borrow, PhD · Public Health England

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-03-31
Completion
2012-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00962624 on ClinicalTrials.gov